Recombinant chicken monoclonal antibody specially binds to human CENP-B. This anti-CENP-B antibody 5D1 can be potentially wildly used in the treatment of systemic sclerosis.
Figure 1 Human epithelial cell line (HeLa) extracts were prepared by sonication and Western blotted onto nitrocellulose membrane.
Molecular weights (kDa) of marker proteins are indicated on the left.
Hof, D., Hoeke, M. O., & Raats, J. M. H. (2008). Multiple‐antigen immunization of chickens facilitates the generation of recombinant antibodies to autoantigens. Clinical & Experimental Immunology, 151(2), 367-377.
Figure 2 Chicken serum enzyme-linked immunosorbent assay (ELISA).
Pre-immune and immune sera of chickens 1 and 2 were tested for reactivity with centromere protein B.
Hof, D., Hoeke, M. O., & Raats, J. M. H. (2008). Multiple‐antigen immunization of chickens facilitates the generation of recombinant antibodies to autoantigens. Clinical & Experimental Immunology, 151(2), 367-377.
Figure 3 Immunostaining of human colon tissue with anti CENP-B antibodies.
At least 300 dots of cells were counted.
Tomonaga, T., Matsushita, K., Yamaguchi, S., Oohashi, T., Shimada, H., Ochiai, T., ... & Nomura, F. (2003). Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer research, 63(13), 3511-3516.
Figure 4 CENP-B is degraded in the TR-ICP0.39 cell line.
Immunofluorescence study showing the correct ICP0 expression and activity in the TRICP0.39 (TR-ICP0) cell line.
Tomonaga, T., Matsushita, K., Yamaguchi, S., Oohashi, T., Shimada, H., Ochiai, T., ... & Nomura, F. (2003). Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer research, 63(13), 3511-3516.
Figure 5 ICP0 induces the degradation of cenpB in mouse cells.
Anti-CENP-B was used to specifically detect cenpB (green).
Tomonaga, T., Matsushita, K., Yamaguchi, S., Oohashi, T., Shimada, H., Ochiai, T., ... & Nomura, F. (2003). Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer research, 63(13), 3511-3516.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1127z | Mouse Anti-CENPB Recombinant Antibody (clone 25B8) | WB, IP, IF, ELISA | Mouse IgG2a, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0662 | Hi-Affi™ Rabbit Anti-CENPB Recombinant Antibody (clone DS662AB) | WB, IP | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0002JF-F(E) | Chicken Anti-CENPB Recombinant Antibody (clone 5D1); Fab Fragment | IB, WB, ELISA, FuncS | Chicken Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0002JF-S(P) | Chicken Anti-CENPB Recombinant Antibody (clone 5D1); scFv Fragment | IB, WB, ELISA, FuncS | Chicken scFv |
There are currently no Customer reviews or questions for FAMAB-0002JF. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.